Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 428


In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis.

Riteau N, Bernaudin JF.

Eur Respir J. 2020 Mar 26;55(3). pii: 2000149. doi: 10.1183/13993003.00149-2020. Print 2020 Mar. No abstract available.


What is the place of hematopoietic stem cell transplantation in the management of cerebral vasculopathy in children with sickle cell anemia?

Bernaudin F.

Hematol Oncol Stem Cell Ther. 2020 Mar 12. pii: S1658-3876(20)30017-0. doi: 10.1016/j.hemonc.2019.12.002. [Epub ahead of print] Review.


[Is hypoxia a factor in the progression of pulmonary sarcoidosis?]

Jeny F, Bernaudin JF, Valeyre D, Nunes H, Planès C, Besnard V.

Rev Mal Respir. 2020 Mar 4. pii: S0761-8425(20)30037-1. doi: 10.1016/j.rmr.2020.02.006. [Epub ahead of print] French.


Correction for Magnetic Field Inhomogeneities and Normalization of Voxel Values Are Needed to Better Reveal the Potential of MR Radiomic Features in Lung Cancer.

Lacroix M, Frouin F, Dirand AS, Nioche C, Orlhac F, Bernaudin JF, Brillet PY, Buvat I.

Front Oncol. 2020 Jan 31;10:43. doi: 10.3389/fonc.2020.00043. eCollection 2020.


Diagnosis issues in sarcoidosis.

Jeny F, Bernaudin JF, Cohen Aubart F, Brillet PY, Bouvry D, Nunes H, Valeyre D.

Respir Med Res. 2019 Oct 28;77:37-45. doi: 10.1016/j.resmer.2019.09.002. [Epub ahead of print]


Patient Registries in Idiopathic Pulmonary Fibrosis: Don't Forget Socioeconomic Status.

Sesé L, Cavalin C, Bernaudin JF, Annesi Maesano I, Nunes H.

Am J Respir Crit Care Med. 2020 Jan 15. doi: 10.1164/rccm.201911-2275LE. [Epub ahead of print] No abstract available.


Hadrontherapy Interactions in Molecular and Cellular Biology.

Thariat J, Valable S, Laurent C, Haghdoost S, Pérès EA, Bernaudin M, Sichel F, Lesueur P, Césaire M, Petit E, Ferré AE, Saintigny Y, Skog S, Tudor M, Gérard M, Thureau S, Habrand JL, Balosso J, Chevalier F.

Int J Mol Sci. 2019 Dec 24;21(1). pii: E133. doi: 10.3390/ijms21010133. Review.


64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study.

Pérès EA, Toutain J, Paty LP, Divoux D, Ibazizène M, Guillouet S, Barré L, Vidal A, Cherel M, Bourgeois M, Bernaudin M, Valable S.

EJNMMI Res. 2019 Dec 19;9(1):114. doi: 10.1186/s13550-019-0586-6.


Radionuclide spatial distribution and dose deposition for in vitro assessments of 212 Pb-αVCAM-1 targeted alpha therapy.

Frelin-Labalme AM, Roger T, Falzone N, Quan Lee B, Sibson NR, Vallis KA, Bernaudin M, Valable S, Corroyer-Dulmont A.

Med Phys. 2020 Mar;47(3):1317-1326. doi: 10.1002/mp.13969. Epub 2020 Jan 30.


Serum Immunoglobulin Levels in Children with Sickle Cell Disease: A Large Prospective Study.

Cherif-Alami S, Hau I, Arnaud C, Kamdem A, Coulon B, Idoux E, Bechet S, Creidy R, Bernaudin F, Epaud R, Pondarré C.

J Clin Med. 2019 Oct 15;8(10). pii: E1688. doi: 10.3390/jcm8101688.


Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France.

Brousse V, Arnaud C, Lesprit E, Quinet B, Odièvre MH, Etienne-Julan M, Guillaumat C, Elana G, Belloy M, Garnier N, Chamouine A, Dumesnil C, Montalembert M, Pondarre C, Bernaudin F, Couque N, Boutin E, Bardakjian J, Djennaoui F, Ithier G, Benkerrou M, Thuret I.

J Clin Med. 2019 Oct 2;8(10). pii: E1594. doi: 10.3390/jcm8101594.


How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer.

Lange M, Castel H, Le Fel J, Tron L, Maillet D, Bernaudin M, Touzani O, Perrier J, Boone M, Licaj I, Giffard B, Dubois M, Rigal O, Durand T, Belin C, Ricard D, Le Gal R, Pancré V, Hardy-Léger I, Joly F.

Neurosci Biobehav Rev. 2019 Dec;107:602-614. doi: 10.1016/j.neubiorev.2019.09.028. Epub 2019 Sep 22. Review.


VCAM-1 targeted alpha-particle therapy for early brain metastases.

Corroyer-Dulmont A, Valable S, Falzone N, Frelin-Labalme AM, Tietz O, Toutain J, Soto MS, Divoux D, Chazalviel L, Pérès EA, Sibson NR, Vallis KA, Bernaudin M.

Neuro Oncol. 2020 Mar 5;22(3):357-368. doi: 10.1093/neuonc/noz169.


Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy.

Magnani A, Pondarré C, Bouazza N, Magalon J, Miccio A, Six E, Roudaut C, Arnaud C, Kamdem A, Touzot F, Gabrion A, Magrin E, Couzin C, Fusaro M, André I, Vernant JP, Gluckman E, Bernaudin F, Bories D, Cavazzana M.

Haematologica. 2019 Sep 19. pii: haematol.2019.227561. doi: 10.3324/haematol.2019.227561. [Epub ahead of print]


Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.

Eapen M, Brazauskas R, Walters MC, Bernaudin F, Bo-Subait K, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Bolaños-Meade J, Panepinto JA, Rondelli D, Shenoy S, Williamson J, Woolford TL, Gluckman E, Wagner JE, Tisdale JF.

Lancet Haematol. 2019 Nov;6(11):e585-e596. doi: 10.1016/S2352-3026(19)30154-1. Epub 2019 Sep 5.


Potential for Nuclear Medicine Therapy for Glioblastoma Treatment.

Bailly C, Vidal A, Bonnemaire C, Kraeber-Bodéré F, Chérel M, Pallardy A, Rousseau C, Garcion E, Lacoeuille F, Hindré F, Valable S, Bernaudin M, Bodet-Milin C, Bourgeois M.

Front Pharmacol. 2019 Jul 10;10:772. doi: 10.3389/fphar.2019.00772. eCollection 2019. Review.


Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma.

Gérard M, Corroyer-Dulmont A, Lesueur P, Collet S, Chérel M, Bourgeois M, Stefan D, Limkin EJ, Perrio C, Guillamo JS, Dubray B, Bernaudin M, Thariat J, Valable S.

Front Med (Lausanne). 2019 Jun 12;6:117. doi: 10.3389/fmed.2019.00117. eCollection 2019. Review.


Expression of SAA1, SAA2 and SAA4 genes in human primary monocytes and monocyte-derived macrophages.

Jumeau C, Awad F, Assrawi E, Cobret L, Duquesnoy P, Giurgea I, Valeyre D, Grateau G, Amselem S, Bernaudin JF, Karabina SA.

PLoS One. 2019 May 17;14(5):e0217005. doi: 10.1371/journal.pone.0217005. eCollection 2019.


Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.

Bernaudin F, Dalle JH, Bories D, de Latour RP, Robin M, Bertrand Y, Pondarre C, Vannier JP, Neven B, Kuentz M, Maury S, Lutz P, Paillard C, Yakouben K, Thuret I, Galambrun C, Dhedin N, Jubert C, Rohrlich P, Bay JO, Suarez F, Raus N, Vernant JP, Gluckman E, Poirot C, Socié G; Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Haematologica. 2020 Jan;105(1):91-101. doi: 10.3324/haematol.2018.213207. Epub 2019 May 16.

Supplemental Content

Loading ...
Support Center